Prevest Denpro Ltd.

Prevest Denpro Ltd.

BBSE:PREVEST
386.00
INR
-6.80
(-1.73%)
18.10EPS
20.74P/E
4.50BMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
21.82
25.77
31.06
31.76
41.55
46.58
51.72
59.06
62.58
Basic EPS, GAAP
3.39
5.67
8.16
9.64
13.09
13.44
15.13
17.07
18.1
Free Cash Flow per Basic Share
3.41
5.35
9.91
5.8
8.89
9.68
12.34
12.34
- -
Dividend per Share
- -
- -
- -
- -
- -
0.26
1
1
- -
Book Value per Share
8.58
12.75
18.17
45.48
60.65
73.83
87.95
103.97
- -
Tangible Book Value per Share
8.58
12.75
18.17
45.48
60.65
73.83
87.95
103.89
- -
Basic Weighted Avg Shares
9
9
9
12
12
12
12
12
12
Sales/Revenue/Turnover
193
228
274
381
499
559
621
709
751
Operating Margin (%)
18.01
20.86
31.22
38.57
38.38
33.59
33.04
32.41
32.11
Depreciation Expense
4
4
5
5
7
13
19
20
20
Net Income, GAAP
30
50
72
116
157
161
182
205
217
Effective Tax Rate (%)
20.3
20.21
22.8
27.93
25.04
24.71
25.13
25.79
25.56
Profit Margin (%)
15.53
22
26.26
30.36
31.51
28.86
29.25
28.9
28.92
Working Capital
67
118
171
473
489
626
798
994
- -
LT Debt
14
16
14
14
- -
- -
- -
- -
- -
Total Equity
103
153
225
571
728
886
1,056
1,248
- -
Return on Invested Capital (%)
- -
26.51
31.75
25.44
21.84
17.48
15.72
14.77
- -
Return on Capital (%)
- -
35.96
36
28.28
23.94
19.99
18.7
17.79
- -
Return on Common Equity (%)
- -
39.13
38.84
30.29
24.66
19.99
18.7
17.79
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
5,899
4,103
4,505

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
1,065
- -
Cash, Cash Equivalents & STI
- -
815
- -
Accounts Receivable, Net
- -
87
- -
Inventories
- -
109
- -
Total Current Liabilities
- -
71
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
48.07%
18.21%
Free Cash Flow
- -
13.82%
-0.06%
Net Income, GAAP
- -
24.88%
12.86%
Sales/Revenue/Turnover
- -
21.42%
14.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
134
163
149
185
621
2026
158
186
185
189
709
2027
191
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
3.06
4.01
3.77
4.28
15.13
2026
3.67
4.62
3.93
4.85
17.07
2027
4.7
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
1
2027
- -
- -
- -
- -
- -

Company Description

CEO
Atul Modi
Full Time Employees
139
Sector
Health technology
Industry
Medical specialties
Address
Export Promotion Industrial Park Samba India 181133
IPO Date
Sep 27, 2021
Business
Prevest Denpro Limited is an India-based manufacturer specializing in dental materials and equipment, serving both domestic and international markets. Founded in 1999 and headquartered in Jammu, Jammu & Kashmir, the company manufactures and markets a comprehensive range of dental consumables and materials. Its main product portfolio includes clinical dental materials such as adhesives, bonding agents, etchants, auxiliaries, cements, liners, composites, endodontic materials, finishing and polishing products, impression materials, oral care products, orthodontic materials, retraction materials, temporaries, and tooth whitening products. Additionally, it offers laboratory products including acrylics, auxiliaries, base plates, waxes, and gypsum products. The company is a leading manufacturer of high-quality 3D printing dental resins used for fabricating crowns, bridges, inlays, onlays, veneers, and surgical guides. It also produces hygiene and disinfectant products formulated to combat bacteria, viruses, and fungi on medical devices and high-touch surfaces. In recent years, Prevest Denpro has expanded its capabilities with the establishment of a new state-of-the-art manufacturing facility focused on oral care products, disinfectants for medical devices, and biomaterials. The company is certified under ISO 13485, CE, MDSAP and has received regulatory clearances from USFDA, Australian TGA, and Saudi FDA, reinforcing its commitment to quality and compliance on a global scale. It has a strong export presence, with its products available in over 80 countries worldwide, driving significant revenue growth, as reflected in its recent financial performance. The company has also been recognized with multiple industry awards including the Best Enterprise Award by the European Business Association and the Best Indian Dental Manufacturer Award by the Indian Dental Association, marking it as a prominent player in the dental materials industry. Prevest Denpro targets dental professionals, clinics, institutions, distributors, and dental laboratories, supporting a wide array of dental disciplines including endodontics, prosthodontics, periodontics, orthodontics, restorative and aesthetic dentistry, and prosthesis fabrication. Its innovative product development is supported by ongoing research and development efforts, emphasizing contract manufacturing and private labeling services for dental consumables. The company maintains manufacturing operations with over 60,000 square feet of production facilities in India, positioning itself as a key specialist in advanced dental solutions and oral healthcare products globally. Overall, Prevest Denpro Limited is a comprehensive dental materials manufacturer known for its extensive range of dental products, global regulatory certifications, recent operational expansion, and strong international presence that supports a diverse customer base across dental and medical device hygiene markets.